In the present study, we demonstrated that RIPK1 expression was significantly upregulated in cells treated with Aβ or cells overexpressing APP, which may lead to the development of necroptosis‐mediated neuronal cell death in AD. Here, RIPK1 is linked to Alzheimer disease.